Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765775283> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2765775283 endingPage "A570" @default.
- W2765775283 startingPage "A570" @default.
- W2765775283 abstract "The 2016 Montgomery report raised concerns about the low acceptance rate for ‘true’ ultra-orphan (TUO) medicines compared to all UO medicines when appraised by the Scottish Medicines Consortium (SMC). We examined possible reasons for ‘not recommended’ SMC advice for TUO medicines and compared appraisals to those conducted by the National Institute for Health and Care Excellence (NICE). The SMC website was searched in April 2017 for detailed advice on all TUO medicines using the search term “ultra orphan”. TUO medicines were defined as per the definition used in the 2016 Montgomery report. The NICE website was also searched to identify equivalent appraisals for each intervention/indication pair. Nine TUO medicines were identified, of which only two were accepted and one was restricted by the SMC (33% acceptance rate), despite the use of Patient and Clinician Engagement meetings and SMC decision modifiers in all appraisals. Of the six ‘not recommended’ medicines, incremental costs in pharmacoeconomic evaluations were typically in excess of £1 million, resulting in incremental cost-effectiveness ratios well above SMC thresholds, and clinical evidence from multi-arm randomised controlled trials was used in only two appraisals. Of the nine TUO medicines assessed by the SMC, four were appraised by NICE for the same indication. Three of these medicines received positive NICE guidance but were not recommended by the SMC; each of these three ‘NICE-recommended’ medicines were assessed via the Highly Specialised Technology process and included restrictions of use/a formal managed access agreement. Compared to NICE, the existing appraisal process used in Scotland for UO medicines does not appear to substantially improve access to TUO medicines; as such, changes to the SMC UO appraisal process may be warranted. ‘Not recommended’ SMC advice is likely related to the high cost and limited evidence base for these medicines, as noted in the 2016 Montgomery report." @default.
- W2765775283 created "2017-11-10" @default.
- W2765775283 creator A5021068069 @default.
- W2765775283 creator A5047055841 @default.
- W2765775283 creator A5061169068 @default.
- W2765775283 creator A5067646340 @default.
- W2765775283 date "2017-10-01" @default.
- W2765775283 modified "2023-09-30" @default.
- W2765775283 title "Why Do ‘True’ Orphan Medicines Have Such A Low Acceptance Rate When Assessed By The SMC?" @default.
- W2765775283 doi "https://doi.org/10.1016/j.jval.2017.08.975" @default.
- W2765775283 hasPublicationYear "2017" @default.
- W2765775283 type Work @default.
- W2765775283 sameAs 2765775283 @default.
- W2765775283 citedByCount "0" @default.
- W2765775283 crossrefType "journal-article" @default.
- W2765775283 hasAuthorship W2765775283A5021068069 @default.
- W2765775283 hasAuthorship W2765775283A5047055841 @default.
- W2765775283 hasAuthorship W2765775283A5061169068 @default.
- W2765775283 hasAuthorship W2765775283A5067646340 @default.
- W2765775283 hasBestOaLocation W27657752831 @default.
- W2765775283 hasConcept C127413603 @default.
- W2765775283 hasConcept C17744445 @default.
- W2765775283 hasConcept C199360897 @default.
- W2765775283 hasConcept C199539241 @default.
- W2765775283 hasConcept C21547014 @default.
- W2765775283 hasConcept C2777352838 @default.
- W2765775283 hasConcept C2779256446 @default.
- W2765775283 hasConcept C41008148 @default.
- W2765775283 hasConcept C512399662 @default.
- W2765775283 hasConcept C60644358 @default.
- W2765775283 hasConcept C71924100 @default.
- W2765775283 hasConcept C75480439 @default.
- W2765775283 hasConcept C86803240 @default.
- W2765775283 hasConceptScore W2765775283C127413603 @default.
- W2765775283 hasConceptScore W2765775283C17744445 @default.
- W2765775283 hasConceptScore W2765775283C199360897 @default.
- W2765775283 hasConceptScore W2765775283C199539241 @default.
- W2765775283 hasConceptScore W2765775283C21547014 @default.
- W2765775283 hasConceptScore W2765775283C2777352838 @default.
- W2765775283 hasConceptScore W2765775283C2779256446 @default.
- W2765775283 hasConceptScore W2765775283C41008148 @default.
- W2765775283 hasConceptScore W2765775283C512399662 @default.
- W2765775283 hasConceptScore W2765775283C60644358 @default.
- W2765775283 hasConceptScore W2765775283C71924100 @default.
- W2765775283 hasConceptScore W2765775283C75480439 @default.
- W2765775283 hasConceptScore W2765775283C86803240 @default.
- W2765775283 hasIssue "9" @default.
- W2765775283 hasLocation W27657752831 @default.
- W2765775283 hasOpenAccess W2765775283 @default.
- W2765775283 hasPrimaryLocation W27657752831 @default.
- W2765775283 hasRelatedWork W1904858586 @default.
- W2765775283 hasRelatedWork W1935811877 @default.
- W2765775283 hasRelatedWork W2013151644 @default.
- W2765775283 hasRelatedWork W2073681061 @default.
- W2765775283 hasRelatedWork W2766231777 @default.
- W2765775283 hasRelatedWork W2783980042 @default.
- W2765775283 hasRelatedWork W2899084033 @default.
- W2765775283 hasRelatedWork W2995092704 @default.
- W2765775283 hasRelatedWork W4206432427 @default.
- W2765775283 hasRelatedWork W4298329110 @default.
- W2765775283 hasVolume "20" @default.
- W2765775283 isParatext "false" @default.
- W2765775283 isRetracted "false" @default.
- W2765775283 magId "2765775283" @default.
- W2765775283 workType "article" @default.